Abiopharma

SeaStar Medical Announces 1-for-10 Reverse Split

Janux - Investor Relations - Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study

Henry Schein Provides Update on CEO Search Process

Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study

Organogenesis Announces Initiation of Biologics License Application for ReNu®

Perrigo Company plc (PRGO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors

Integer Holdings Corporation (ITGR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm